NDC 52856-505 – Emflaza

Deflazacort 22.75 mg/mL · Suspension · Oral

Human Prescription Drug

Product NDC52856-505

Product details

Brand name
Emflaza
Generic name
deflazacort
Labeler
PTC Therapeutics, Inc.
Dosage form
Suspension
Route
Oral
Marketing category
NDA · NDA208685
Marketed since
September 10, 2018
Listing expires
December 31, 2026
Pharmacologic class
Corticosteroid

Active ingredients

Uses, dosage, side effects and warnings for Emflaza →

Package NDC codes (1)

Package NDCDescriptionSince
52856-505-2213 mL in 1 BOTTLE (52856-505-22)Aug 30, 2019

Other Emflaza products